Forbes contributors publish independent expert analyses and insights. Dara-Abasi Ita covers AI in boring asset classes and boring markets. This voice experience is generated by AI. Learn more. This ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ORIC Pharmaceuticals advances rinzimetostat into the global Phase 3 Himalayas-1 trial for mCRPC, with full global rights.
FISHERS, INDIANA - July 30, 2025 (NEWMEDIAWIRE) - Royalty Management Holding Corporation (Nasdaq: RMCO) ("Royalty Management" "RMCO", or the "Company"), a forward leaning royalty company building ...
June 24 (Reuters) - Royalty Pharma (RPRX.O), opens new tab will pay up to $2 billion to Revolution Medicines (RVMD.O), opens new tab to support the development and sales of an experimental drug to ...
We tend to think there are two means by which to invest in gold. Via the metal – coins, bars, futures and so on – or via a company that mines it. The metal is the safer option, but (assuming it all ...
Aug 25 (Reuters) - Royalty Pharma (RPRX.O), opens new tab has agreed to buy a royalty interest in Amgen's (AMGN.O), opens new tab drug for small cell lung cancer from BeOne Medicines (688235.SS), ...
(Reuters) -Royalty Pharma has agreed to buy a royalty interest in Amgen's drug for small cell lung cancer from BeOne Medicines for up to $950 million, it said on Monday. Shares of biotech investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results